Presentation at WIPO Design Law Treaty diplcom side event
Article-3-WIPO-DLT-18nov2024
KEI closing statement at INB 12
KEI closing statement at INB 12 Geneva Friday, 15 November 2024 We welcome the decision to provide daily access to the negotiating texts, but more needs to be done on transparency. The excessive secrecy surrounding the WHO pandemic treaty is… Continue Reading
INB12: KEI statement on Article 11 on the transfer of technology and know-how for the production of pandemic related health products
On Thursday, 14 November 2024, Knowledge Ecology International (KEI) delivered the following statement on Article 11 on the transfer of technology and know-how for the production of pandemic related health products. In several interventions and in talks with negotiators, KEI… Continue Reading
KEI Briefing Note 2024:8. The Basic Proposal for the Design Law Treaty (DLT) and its inappropriate restrictions on transparency
kei-bn-2024-8 KEI Briefing Note 2024:8. The Basic Proposal for the Design Law Treaty (DLT) and its inappropriate restrictions on transparency November 12, 2024
KEI Briefing Note 2024:8, The Basic Proposal for the Design Law Treaty (DLT) and its inappropriate restrictions on transparency
kei-bn-2024-8 KEI Briefing Note 2024:8 The Basic Proposal for the Design Law Treaty (DLT) and its inappropriate restrictions on transparency November 12, 2024
INB12: KEI talking points on Article 11 Transfer of technology and know-how for the production of pandemic-related health products
KEI talking points on Article 11 7 November 2024 The proposed New 1(j) footnote under Article 11 for INB12 is a complex way of saying that countries will make efforts to negotiate voluntary agreements on technology transfer, but if that… Continue Reading
Proposal for Addition Of Risdiplam to WHO Model List Of Essential Medicines, for the treatment of Spinal Muscular Atrophy (SMA).
On November 1, 2024, Knowledge Ecology International (KEI) submitted a proposal for the addition of risdiplam to the World Health Organization’s (WHO) Model List of Essential Medicine (EML). You can access the full proposal here: risdiplam2WHOEML1Nov2024 The EML, updated every… Continue Reading
KEI Comments to NIH on Exclusive License to T-Cure Biosciences for Anti-KK-LC-1 T Cell Receptors Patents
KEI-NIH-T-Cure-Biosciences22Oct2024 Knowledge Ecology International (KEI) objects to the “Prospective Grant of an Exclusive Patent License: Anti-KK-LC-1 T Cell Receptors” (89 FR 81089) to T-Cure Biosciences, Inc. (T-Cure). Among other things, KEI said the NIH needs to be more forthcoming in… Continue Reading
KEI Letter to USPTO on WIPO Design Law Treaty Federal Funding Disclosure Issue
Knowledge Ecology International (KEI) has sent a letter to Katherine Vidal, Under Secretary of Commerce for Intellectual Property and Director of the U.S. Patent and Trademark Office (USPTO) concerning an issue in Article 3 of the the World Intellectual Property… Continue Reading
SCP 36: Brazil’s intervention on patents and health
On Wednesday morning, 16 October 2024, Brazil delivered the following intervention on patents and health at the 36th session of the WIPO Standing Committee on the Law of Patents (SCP) — Brazil’s intervention for the SCP Session on Patent Flexibilities… Continue Reading